SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001341004-19-000394
Filing Date
2019-06-07
Accepted
2019-06-07 16:04:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D, AMENDMENT NO. 3 sc13d-a3.htm SC 13D/A 73116
2 EXHIBIT 4 - STANDSTILL AGREEMENT ex4.htm EX-99.1 57396
  Complete submission text file 0001341004-19-000394.txt   132015
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filed by) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89674 | Film No.: 19885697
SIC: 2836 Biological Products, (No Diagnostic Substances)